Acurx Pharmaceuticals Inc (ACXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,600 | -5,931 | N/A | N/A | N/A |
| Other Working Capital | -801 | 1,046 | N/A | N/A | N/A |
| Other Operating Activity | 2,050 | 900 | 0 | 0 | 0 |
| Operating Cash Flow | $-3,352 | $-3,985 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 4,044 | 4,455 | 0 | 0 | 0 |
| Financing Cash Flow | $4,044 | $4,455 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 2,483 | 2,013 | N/A | N/A | N/A |
| End Cash Position | 3,175 | 2,483 | N/A | N/A | N/A |
| Net Cash Flow | $692 | $470 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,352 | -3,985 | N/A | N/A | N/A |
| Free Cash Flow | -3,352 | -3,985 | 0 | 0 | 0 |